Interestingly, no modulation was demonstrated on the number of IL-21R positive B cells in T2D patients, whereas a moderate reduction of IL-21R monocytes was determined (Additional file 2: Figure S2C, D). This evidence concerns the gene IL21R and type 2 diabetes mellitus.